• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

耐万古霉素金黄色葡萄球菌:感染控制考量

Vancomycin-resistant Staphylococcus aureus: infection control considerations.

作者信息

Wenzel R P, Edmond M B

机构信息

Department of Internal Medicine, Medical College of Virginia Campus of Virginia Commonwealth University, Richmond 23298-0663, USA.

出版信息

Clin Infect Dis. 1998 Aug;27(2):245-9; quiz 250-1. doi: 10.1086/514646.

DOI:10.1086/514646
PMID:9709870
Abstract

The lessons of the antibiotic era are crystal clear: in the footrace between humans and microbes, the organisms' genetic repertoire and efficient response to environmental changes will win the day. New antibiotics are essential, but their shelf life will be enhanced only if used wisely and sparingly. The antibiotic era is continually threatened by inappropriate decisions regarding use, inappropriate choices, and unnecessary durations of treatment. In concert with improved prescribing habits, efforts to identify and isolate resistant organisms introduced from outside institutions are essential. Last, continual energy is needed to influence the behavior of health care professionals and to maintain optimal infection control policies and procedures. We remain optimistic about the ability of infectious diseases physicians to respond appropriately to continued microbial challenges with research, education, and wise practice.

摘要

抗生素时代的教训清晰明了

在人类与微生物的竞赛中,微生物的基因库及其对环境变化的高效反应将最终取胜。新型抗生素至关重要,但只有明智且谨慎地使用,其有效期才会延长。抗生素时代不断受到用药决策不当、选择不当以及治疗疗程不必要等问题的威胁。与改善处方习惯相结合,识别和隔离外部机构引入的耐药菌的努力至关重要。最后,需要持续投入精力来影响医护人员的行为,并维持最佳的感染控制政策和程序。我们对传染病医生通过研究、教育和明智的实践来妥善应对持续的微生物挑战的能力仍持乐观态度。

相似文献

1
Vancomycin-resistant Staphylococcus aureus: infection control considerations.耐万古霉素金黄色葡萄球菌:感染控制考量
Clin Infect Dis. 1998 Aug;27(2):245-9; quiz 250-1. doi: 10.1086/514646.
2
Control of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus in hospitalized children.住院儿童耐甲氧西林金黄色葡萄球菌和耐万古霉素肠球菌的控制
Pediatr Infect Dis J. 1998 Sep;17(9):825-6. doi: 10.1097/00006454-199809000-00017.
3
Vancomycin-resistant Staphylococcus aureus: perspectives on measures needed for control.耐万古霉素金黄色葡萄球菌:控制所需措施的观点
Ann Intern Med. 1996 Feb 1;124(3):329-34. doi: 10.7326/0003-4819-124-3-199602010-00008.
4
Vancomycin-resistant Staphylococcus aureus.
Ann Intern Med. 1996 Nov 15;125(10):859; author reply 859-60. doi: 10.7326/0003-4819-125-10-199611150-00017.
5
Vancomycin-resistant Staphylococcus aureus.
Ann Intern Med. 1996 Nov 15;125(10):858-9; author reply 859-60. doi: 10.7326/0003-4819-125-10-199611150-00015.
6
Vancomycin-resistant Staphylococcus aureus.
Ann Intern Med. 1996 Nov 15;125(10):858; author reply 859-60. doi: 10.7326/0003-4819-125-10-199611150-00014.
7
Use of enteral vancomycin for the control of methicillin-resistant Staphylococcus aureus in intensive care units.在重症监护病房使用肠内万古霉素控制耐甲氧西林金黄色葡萄球菌。
J Hosp Infect. 2005 Mar;59(3):259-61; author reply 263-6. doi: 10.1016/j.jhin.2004.08.002.
8
Reduced susceptibility of Staphylococcus aureus to vancomycin--Japan, 1996.1996年日本金黄色葡萄球菌对万古霉素的敏感性降低
MMWR Morb Mortal Wkly Rep. 1997 Jul 11;46(27):624-6.
9
An emerging superbug. Staphylococcus aureus becomes less susceptible to vancomycin.一种新出现的超级细菌。金黄色葡萄球菌对万古霉素的敏感性降低。
MLO Med Lab Obs. 1998 Jan;30(1):26-32; quiz 34-5.
10
Follow these guidelines for resistant S. aureus.
Healthc Benchmarks. 1997 Nov;4(11):164-5.

引用本文的文献

1
Rapid screening of pyogenic for confirmation of genus and species, methicillin resistance and virulence factors by using two novel multiplex PCR.通过使用两种新型多重PCR快速筛查化脓菌以确认其属和种、耐甲氧西林情况及毒力因子。
Pak J Med Sci. 2017 Sep-Oct;33(5):1095-1100. doi: 10.12669/pjms.335.13487.
2
Staphylococcus aureus with reduced susceptibility to vancomycin in healthcare settings.在医疗机构中对万古霉素敏感性降低的金黄色葡萄球菌。
J Prev Med Hyg. 2014 Dec;55(4):137-44.
3
Genetic characterization of a vancomycin-resistant Staphylococcus aureus isolate from the respiratory tract of a patient in a university hospital in northeastern Iran.
伊朗东北部一所大学医院呼吸道患者分离的耐万古霉素金黄色葡萄球菌的遗传特征。
J Clin Microbiol. 2012 Nov;50(11):3581-5. doi: 10.1128/JCM.01727-12. Epub 2012 Aug 29.
4
Nasal colonization of and clonal transmission of methicillin-susceptible Staphylococcus aureus among Chinese military volunteers.中国军事志愿者中耐甲氧西林金黄色葡萄球菌的鼻腔定植和克隆传播。
J Clin Microbiol. 2010 Jan;48(1):64-9. doi: 10.1128/JCM.01572-09. Epub 2009 Nov 4.
5
Update on the appropriate use of linezolid in clinical practice.利奈唑胺在临床实践中合理应用的最新进展。
Ther Clin Risk Manag. 2006 Dec;2(4):455-64. doi: 10.2147/tcrm.2006.2.4.455.
6
Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania.从宾夕法尼亚州一名患者身上分离出的耐万古霉素金黄色葡萄球菌。
Antimicrob Agents Chemother. 2004 Jan;48(1):275-80. doi: 10.1128/AAC.48.1.275-280.2004.
7
Pharmacodynamics of oritavancin (LY333328) in a neutropenic-mouse thigh model of Staphylococcus aureus infection.奥利万星(LY333328)在中性粒细胞减少小鼠金黄色葡萄球菌感染大腿模型中的药效学。
Antimicrob Agents Chemother. 2003 May;47(5):1700-6. doi: 10.1128/AAC.47.5.1700-1706.2003.
8
Daptomycin dose-effect relationship against resistant gram-positive organisms.达托霉素对耐药革兰氏阳性菌的剂量效应关系。
Antimicrob Agents Chemother. 2003 May;47(5):1598-603. doi: 10.1128/AAC.47.5.1598-1603.2003.
9
Vancomycin resistance in staphylococci.葡萄球菌中的万古霉素耐药性。
Clin Microbiol Rev. 2002 Jul;15(3):430-8. doi: 10.1128/CMR.15.3.430-438.2002.
10
Bactericidal activities of two daptomycin regimens against clinical strains of glycopeptide intermediate-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecium, and methicillin-resistant Staphylococcus aureus isolates in an in vitro pharmacodynamic model with simulated endocardial vegetations.在具有模拟心内膜赘生物的体外药效学模型中,两种达托霉素给药方案对糖肽类中介耐药金黄色葡萄球菌、耐万古霉素粪肠球菌和耐甲氧西林金黄色葡萄球菌临床分离株的杀菌活性。
Antimicrob Agents Chemother. 2001 Feb;45(2):454-9. doi: 10.1128/AAC.45.2.454-459.2001.